BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12871107)

  • 1. New antiviral nucleoside prodrugs await application.
    Anastasi C; Quéléver G; Burlet S; Garino C; Souard F; Kraus JL
    Curr Med Chem; 2003 Sep; 10(18):1825-43. PubMed ID: 12871107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.
    Sinokrot H; Smerat T; Najjar A; Karaman R
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29035325
    [No Abstract]   [Full Text] [Related]  

  • 3. Nucleoside diphosphate and triphosphate prodrugs - An unsolvable task?
    Meier C
    Antivir Chem Chemother; 2017 Dec; 25(3):69-82. PubMed ID: 29096525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs.
    Madela K; McGuigan C
    Future Med Chem; 2012 Apr; 4(5):625-50. PubMed ID: 22458682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in antiviral nucleoside analogues and their prodrugs.
    Seley-Radtke K; Deval J
    Antivir Chem Chemother; 2018; 26():2040206618781410. PubMed ID: 29890841
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs.
    Luo M; Groaz E; Andrei G; Snoeck R; Kalkeri R; Ptak RG; Hartman T; Buckheit RW; Schols D; De Jonghe S; Herdewijn P
    J Med Chem; 2017 Jul; 60(14):6220-6238. PubMed ID: 28682067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection.
    Dousson CB
    Antivir Chem Chemother; 2018; 26():2040206618756430. PubMed ID: 29463095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs.
    Cho JH; Bondana L; Detorio MA; Montero C; Bassit LC; Amblard F; Coats SJ; Schinazi RF
    Bioorg Med Chem; 2014 Dec; 22(23):6665-6671. PubMed ID: 25458500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodrugs of Nucleoside Triphosphates as a Sound and Challenging Approach: A Pioneering Work That Opens a New Era in the Direct Intracellular Delivery of Nucleoside Triphosphates.
    Camarasa MJ
    ChemMedChem; 2018 Sep; 13(18):1885-1889. PubMed ID: 30152096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and broad spectrum antiviral evaluation of bis(POM) prodrugs of novel acyclic nucleosides.
    Hamada M; Roy V; McBrayer TR; Whitaker T; Urbina-Blanco C; Nolan SP; Balzarini J; Snoeck R; Andrei G; Schinazi RF; Agrofoglio LA
    Eur J Med Chem; 2013 Sep; 67():398-408. PubMed ID: 23911854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-HCV activity of a series of β-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs.
    Chen Z; Cox BD; Garnier-Amblard EC; McBrayer TR; Coats SJ; Schinazi RF; Amblard F
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5296-5299. PubMed ID: 29066308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals.
    Krecmerova M
    Mini Rev Med Chem; 2017; 17(10):818-833. PubMed ID: 28215138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
    Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
    Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors.
    Hurwitz SJ; Schinazi RF
    Curr Opin HIV AIDS; 2013 Nov; 8(6):556-64. PubMed ID: 24100876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryloxy phosphoramidate triesters as pro-tides.
    Cahard D; McGuigan C; Balzarini J
    Mini Rev Med Chem; 2004 May; 4(4):371-81. PubMed ID: 15134540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclic nucleoside phosphonates: a key class of antiviral drugs.
    De Clercq E; Holý A
    Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
    Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
    Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
    Balzarini J; Haller-Meier F; De Clercq E; Meier C
    Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexibility-Not just for yoga anymore!
    Seley-Radtke K
    Antivir Chem Chemother; 2018; 26():2040206618756788. PubMed ID: 29466861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodrugs of Nucleoside 5'-Monophosphate Analogues: Overview of the Recent Literature Concerning their Synthesis and Applications.
    Roy B; Navarro V; Peyrottes S
    Curr Med Chem; 2023; 30(11):1256-1303. PubMed ID: 36093825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.